Learn about the program's unique curriculum, world-class faculty and convenient schedule. In just two years, you can earn your degree while still working full-time.
Richard Moss, Ph.D.
Senior Associate Dean for Basic Research, Biotechnology and Graduate Studies
Executive Director and Co-founder, M.S. in Biotechnology Program
Professor
Kurt Zimmerman, M.S.
Director, Industry Engagement, SMPH
Director, Master of Science in Biotechnology Program
Natalie Betz, Ph.D.
Associate Director and Faculty Instructor, Master of Science in Biotechnology Program
Bryan Husk, M.A.
Assistant Director, Master of Science in Biotechnology Program
Michele Smith, MS SCT(ASCP)
Program Manager, Master of Science in Biotechnology Program
The Master of Science of Biotechnology Program brings together the expertise of the University of Wisconsin's world-class faculty, and the applied experience of the region's most successful biotechnology leaders from private industry.
Colleen Adams, MTSC
Director, Regulatory Affairs
Exact Sciences
Natalie Betz, Ph.D.
Associate Director and Faculty Instructor
Master of Science in Biotechnology
Karin Borgh, Ph.D.
Executive Director of BTCI
BioPharmaceutical Technology Center Institute
Tom Burke, Ph.D.
Director of Genome Engineering
Cellular Dynamics International Inc.
Russ Coff, Ph.D.
Associate Dean of Research,
Professor, Management & Human Resources
Wisconsin School of Business
Abigail Davis, M.S.
Senior Quality Assurance Manager
Promega Corporation
Hansi Dean, Ph.D.
Vice President and Head, Discovery Research
Takeda Pharmaceuticals USA, Inc.
Ed Elder, Ph.D., R.Ph.
Director, Zeeh Pharmaceutical Experiment Station
UW-Madison, School of Pharmacy
Michael Falk, J.D., M.B.A.
General Counsel
Wisconsin Alumni Research Foundation
Scott Fulton, M.S.
Founder and CEO
Cellera, LLC
Fabio Gaertner, Ph.D.
Assistant Professor of Accounting & Information Systems
Wisconsin School of Business
Martin Ganco, Ph.D.
Associate Professor, Management & Human Resources
Wisconsin School of Business
Heather Gerard, M.S.
Intellectual Property Manager
Promega Corporation
Jennifer Gottwald, Ph.D.
Licensing Manager
Wisconsin Alumni Research Foundation
Susan LaBelle, M.B.A.
Managing Director
Office of Corporate Relations
Dave Lewis, Ph.D.
Chief Scientific Officer (former)
Arrowhead Research
Thomas Machleidt, Ph.D.
Senior Research Scientist
Promega Corporation
Jessica Martin Eckerly, M.B.A., M.S.
CEO and Co-Founder
Forward BIOLABS
Terri McDonnell, M.B.A.
Senior Program Manager
Promega Corporation
Pilar Ossorio, Ph.D., J.D.
Professor of Law and Bioethics
University of Wisconsin Law School
Hart Posen, Ph.D., M.B.A.
Associate Professor, Management & Human Resources
Wisconsin School of Business
Marla Rybowiak
Director of Operations
The Employer Group
Chris Sebranek, M.S.
Director Of Quality Assurance
LSNE Contract Manufacturing
Ben Seffrood M.B.A., M.S.
Head of Finance
Roche NimbleGen
Laura Strong, Ph.D.
President and COO
Quintessence Biosciences
Charlie Trevor, Ph.D.
Professor, Management & Human Resources
Wisconsin School of Business
Michelle Venturini, M.B.A., SPHR
Adjunct Professor
Cheryl Vickroy, M.B.A.
Director
Center for Technology Commercialization
Eric B. Vincent, Ph.D.
Global Product Manager
Promega Corporation
Mary Wang, M.A.
ESL Instructor
English as a Second Language, English Department
Mary Westrick, Ph.D.
Vice President, US Phase I (retired)
Quintiles
Scott Wildman, Ph.D.
Computational Chemist
UW Carbone Cancer Center
Jonathan Young, Ph.D.
Head of WARF Therapeutics
Wisconsin Alumni Research Foundation
The M.S. in Biotechnology program has over 350 alumni since its first graduates in 2004.
Each year the value of the alumni network strengthens as more students graduate and grow their careers.
Alumni by Graduating Class:
Instructors:
This powerful exploration of drug-discovery topics and concepts puts students in the role of scientists researching an inhibitor of Src Protein Kinase as a new drug therapy.
Hands-on laboratory sessions cover state-of-the-art assays, methods and data analysis used in primary and advanced levels of drug screening.
You'll focus on detecting kinase activity as a model for a relevant drug target, evaluate the effect of two putative inhibitors identified from a compound library during an initial screen and assess how the identified inhibitors effects cytochrome P450 activity and cell viability.
You'll gain experience with basic cell culture techniques, stem cell biology, fluorescent microscopy and high content screening. And as you master course concepts and lab practices, you'll also hone your scientific communication skills with short papers and a detailed scientific protocol.
Here are some of the topics taught in this course:
Session 1: Introduction to MTIII; Introduction to the Drug Discovery Process and Targets; Introduction to Kinase and P450 Enzymes and Assay Technologies; Thermo Fisher Drug Screening Service Laboratory Tour
Session 2: Introduction to Data Analysis; Kinase Assay Laboratory; Introduction to the Final Capstone Project; Business Concepts Refresher
Session 3: Cytochrome P450 Technology Laboratory and Introduction to Cell Culture and Cell-Based Assays
Session 4: Introduction to Fluorescent Microscopy, High Content Screening, and In Vivo Imaging; Basic Cell Culture Laboratory Activities
Session 5: Stem Cells: Introduction and Role in Drug Discovery
Session 6: Cell-Based Assay Laboratory and Introduction to CRISPR
Session 7: Final Presentations
Fall 2019 | Spring 2020
Fall 2020 | Spring 2021
Fall 2020 | Spring 2021
Fall 2021 | Spring 2022
Fall 2021 | Spring 2022
Fall 2022 | Spring 2023
Prospective Students
Biotech at UW-Madison©2020 Board of Regents of the University of Wisconsin System
School of Medicine and Public Health
University of Wisconsin – Madison